Tonix Pharmaceuticals to Present PTSD Clinical Data at the Society of Biological Psychiatry 72nd Annual Scientific Convention
May 11, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-102 SL Composition and Formulation: Designed for Transmucosal Absorption and Bedtime Daily Use
May 02, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update
April 17, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
First Participant Enrolled in Phase 3 HONOR Study of TNX-102 SL in Military-Related PTSD in 1Q2017 TNX-102 SL Designated a Breakthrough Therapy for PTSD by the U.S. FDA in 4Q2016 NEW YORK, April ...
Tonix Pharmaceuticals Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option
April 13, 2017 11:30 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (“Tonix”), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals Reports Results from U.S. FDA Initial Cross-Disciplinary Breakthrough Meeting on TNX-102 SL for Posttraumatic Stress Disorder
April 11, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 11, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals Completes $8 Million Public Offering of Common Stock
April 04, 2017 11:30 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 04, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (“Tonix”), a company that is developing innovative pharmaceutical products to address public...
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
April 03, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, April 03, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals Prices Public Offering of 1,800,000 Shares of Common Stock
March 30, 2017 08:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 30, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (“Tonix”) (Nasdaq:TNXP), a company that is developing innovative pharmaceutical products to address public...
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
March 29, 2017 16:07 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 29, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (“Tonix”), a company that is developing innovative pharmaceutical products to address public health...
Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at The MicroCap Conference
March 29, 2017 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, March 29, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health...